Tango Therapeutics, Inc.
Here’s whether Tango Therapeutics, Inc. (TNGX) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.
Positives: trading above the 200-day MA (long-term uptrend intact); 50-day MA is rising (+0.89% over 10 days); strong 1-year return of +240.7%; 3-month momentum positive (+18.0%). Concerns: below the 50-day MA (medium-term momentum negative). Currently 30.6% off its 52-week high. Score: +4/7.
TNGX is holding above its long-term 200-day MA ($18.81) but has slipped below the 50-day MA ($28.42), pointing to short-term weakness in an otherwise intact trend. An RSI of 34.0 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +240.7% compares to +20.5% for SPY (beat the market by 220.2%). The current 30.6% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.